fda warning letters glp-1 compounders october 2025 ramps up its pushback against compounded GLP-1s U.S. FDA on X: "FDA

We've seen it countless times in conversations with research teams: the terms "Melanotan 1" and "Melanotan 2" are often used interchangeably

N -nitrosobutyl (4-hydroxybutyl) amine (BBN) causes urinary bladder carcinogenesis, and this effect was also suppressed through oltipraz in an Nrf2-dependent manner (Wang et al., 1999

Danielle Kelvas, MD

Die tgliche Einnahme eines L-Carnitin-Ergnzungsmittels erhht nachweislich die Konzentration dieser aminosurehnlichen Verbindung im Blut und in den Muskeln - was den Fettstoffwechsel als Folge der erhhten Muskel-Carnitin-Konzentration verbessern knnte (6)

The website explicitly uses compounded GLP-1 products (not FDA approved), with the disclaimer buried in legalese and clear acknowledgment that these are not branded or FDA-validated versions of Ozempic, Wegovy or any other GLP-1s

These products focus on probiotics and prebiotics, aiming to ease digestive discomfort